With the analysis among 1,036 patents, we discovered top 224 key players by total patent application. F. Hoffmann-La Roche Ltd., Five Prime Therapeutics, Inc., Regeneron Pharmaceuticals, Inc. are dominant in this area. They take 17.18% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Five Prime Therapeutics, Inc.
California, United States
Patent: 48
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 35
GlaxoSmithKline Biologicals SA
Massachusetts, United States
Patent: 23
Theraclone Sciences, Inc.
Washington, United States
Patent: 23
Merrimack Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 17
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 17
Massachusetts, United States
Patent: 17
With the analysis among 123 patents, we discovered top 19 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Autolus Ltd., Synthekine, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 15
California, United States
Patent: 13
Noord-Holland, Netherlands
Patent: 8
California, United States
Patent: 7
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 3
Entos Pharmaceuticals, Inc.
California, United States
Patent: 3
With the analysis among related 645 patents applied in the last 5 years. We discover 200 most active companies in this area. The fast-growing Five Prime Therapeutics, Inc., National Research Council of Canada, United States of America take 15.04% of patent filing during this period.
Five Prime Therapeutics, Inc.
California, United States
Patent: 39
National Research Council of Canada
Ontario, Canada
Patent: 30
F. Hoffmann-La Roche Ltd.
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 18
Department of Health & Human Services
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 17
California, United States
Patent: 15
California, United States
Patent: 13
With the analysis among related 645 patents in last 5 years, we discover 134 new entrants. Autolus Ltd., Boehringer Ingelheim International GmbH, Synthekine, Inc. are the most active new entrants in this area.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 17
California, United States
Patent: 15
California, United States
Patent: 13
California, United States
Patent: 8
St Anna Kinderkrebsforschung
Noord-Holland, Netherlands
Patent: 8
California, United States
Patent: 7
With the analysis among 628 patents, we discovered top 86 universities and scientific research institutions by total patent application. Icahn School of Medicine at Mount Sinai, Yale University, Dartmouth College are dominant in this area. They take 17.36% of the total patent filing.
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 47
Connecticut, United States
Patent: 29
New Hampshire, United States
Patent: 20
Université François-Rabelais de Tours
Minnesota, United States
Patent: 14
Oost-Vlaanderen, Belgium
Patent: 11
Vlaams Instituut voor Biotechnologie - Flanders Institute
Ludwig-Maximilians-Universität München
Bayern, Germany
Patent: 10
University of Massachusetts
Massachusetts, United States
Patent: 8
CENTRE COUNTY, France
Patent: 8